Evidence map›Paper›PMID 41798745›Full record

ArticleFrontiers in cellular and infection microbiology2026

A lytic bacteriophage vB_KpnP-6K2 inhibits ST11-KL64

Zhaoyi Pan, Jing Fan, Xianbo Geng, Shujuan Zhang, Huijiao Zhang, Shujun Liu, Ling Zhang, Guangjian Xue, Rui Li, Tianle Li and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Phage therapy againstFrontiers in microbiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Zhaoyi PanJinan Microecological Biomedicine Shandong Laboratory, Jinan, China.
Jing FanJinan Microecological Biomedicine Shandong Laboratory, Jinan, China.
Xianbo GengJinan Microecological Biomedicine Shandong Laboratory, Jinan, China.
Shujuan ZhangJinan Microecological Biomedicine Shandong Laboratory, Jinan, China.
Huijiao ZhangJinan Microecological Biomedicine Shandong Laboratory, Jinan, China.
Shujun LiuJinan Microecological Biomedicine Shandong Laboratory, Jinan, China.
Ling ZhangJinan Microecological Biomedicine Shandong Laboratory, Jinan, China.
Guangjian XueJinan Microecological Biomedicine Shandong Laboratory, Jinan, China.
Rui LiJinan Microecological Biomedicine Shandong Laboratory, Jinan, China.
Tianle LiJinan Microecological Biomedicine Shandong Laboratory, Jinan, China.
Xiaofeng LiuJinan Microecological Biomedicine Shandong Laboratory, Jinan, China.
Yating YuJinan Microecological Biomedicine Shandong Laboratory, Jinan, China.
Na WangJinan Microecological Biomedicine Shandong Laboratory, Jinan, China.
Changzhong JinJinan Microecological Biomedicine Shandong Laboratory, Jinan, China.
Nanping WuJinan Microecological Biomedicine Shandong Laboratory, Jinan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The global dissemination of multidrug-resistant Methods: Phage 6K2 was morphologically examined by transmission electron microscopy and genomically analyzed via whole-genome sequencing. Its stability across pH and temperature ranges, adsorption kinetics, and burst size were determined Results: Phage 6K2 exhibits a polyhedral head and short tail, classifying it within the Podoviridae family (Autographiviridae family, Discussion: These findings highlight the promising potential of bacteriophage 6K2 as an effective therapeutic agent against multidrug-resistant

Indexed as

BacteriophagesCell DeathKlebsiella InfectionsKlebsiella pneumoniaePhage TherapyA549 CellsAnimalsCell LineCytokinesDisease Models, AnimalEpithelial CellsGenome, ViralHEK293 CellsHeLa CellsHumansInflammationCytokinesbacteriophagebloodstream infectionscell deathinflammatory responseKlebsiella pneumoniae

Identifiers

PMID41798745
PMCPMC12963264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.